Summary of Product Characteristics
last updated on the eMC:
23/01/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 23/01/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
| Date of revision of text on the SPC: 01-Jan-2012 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Sections 7 - Marketing authorisation holder
Section 8 - Marketing authorisation number
|
|
Updated on 27/04/2011 and displayed until 23/01/2012
|
Reasons for adding or updating:
|
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.6 - Pregnancy and Lactation
-
Change to section 4.7 - Effects on Ability to Drive and Use Machines
-
Change to section 4.8 - Undesirable Effects
-
Change to section 4.9 - Overdose
|
| Date of revision of text on the SPC: 01-Apr-2011 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 4.3: Section has been reorganised to improve readability.
Section 4.4: Numerous safety updates have been added to this section.
Section 4.5: Section has been adjusted to improve readability.
Section 4.6: Section has been updated to more accurately reflect current available data.
Section 4.7: Section has been updated to more accurately reflect current available data.
Section 4.8: Section has been updated to organise adverse events by MEDRA system organ class.
Section 4.9: Section had been adjusted to improve safety related wording.
|
|
Updated on 25/07/2007 and displayed until 27/04/2011
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05/2007 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Section 7.1 Change to the MAH address
Section 10 Change in the date of revision
|
|
Updated on 07/01/2002 and displayed until 25/07/2007
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 08/11/2001 and displayed until 07/01/2002
|
Reasons for adding or updating:
|
-
Correction of spelling/typing errors
|
|
Updated on 16/10/2001 and displayed until 08/11/2001
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 17/08/2001 and displayed until 16/10/2001
|
Reasons for adding or updating:
|
-
Change from datasheet to SPC
|
|
Updated on 06/09/1999 and displayed until 17/08/2001
|
Reasons for adding or updating:
|
|
|
|